FDA Releases Draft Risk Assessment and Management Plan for Cloned Animals


Statement of CSPI Biotechnology Director Gregory Jaffe

December 28, 2006

The FDAís draft risk assessment and management plan addressing the food safety issues surrounding cloned animals is better late than never. The agency has been delinquent in waiting five years to begin this public evaluation of cloned animals, requiring consumers to rely on the food industry and cloning companies to voluntarily refrain from introducing cloning animals into the food supply.

We hope the FDAís draft will begin a process in which consumersí number-one concern about cloned animals, their safety as food, will be addressed in a transparent regulatory process using all available scientific evidence. There are many other controversial issues surrounding animal cloning, including ethical and animal welfare concerns. While those arenít food safety issues, there should be a governmental forum to explore them and adopt appropriate policies. Congressional hearings might start a robust societal dialogue on those issues.

Americans want to know that the food on their plates is safe to eat. If FDA ultimately determines that cloned animals are safe to eat and if those cloned animals provide societal benefits, consumers may feel more comfortable about eating those foods. To date, the cloning industry has not provided the public with any information about why cloned animals are needed in food production, who benefits from their use, and how they might benefit the consumer at all.

 

Get Updates Via Email

Journalists can receive CSPI news releases via email.
Not a journalist?

Sign Up for Email Now

NAH

NAH

Subscribe Now

Subscribe Now »

Subscribe Today and Save!

In Recent Issues


Cover Story: What's the Catch? Why the Latest Study is Rarely the Final Answer


Special Feature: Fountain of Youth?


Brand-Name Rating: No-Prep Poultry


NAH
Subscribe Now

Request permission to reuse content

The use of information from this site for commercial purposes is strictly prohibited without written permission from CSPI.

BBB
Guidestar